Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: February 2014
FameLab Hong Kong 2014 Finalist: "Pluripotency – The power of stem cells" by Lo Lok Man – Video
Posted: February 21, 2014 at 10:50 pm
FameLab Hong Kong 2014 Finalist: "Pluripotency - The power of stem cells" by Lo Lok Man
Subject: Pluripotency - The power of stem cells.
By: famelabhk
Excerpt from:
FameLab Hong Kong 2014 Finalist: "Pluripotency - The power of stem cells" by Lo Lok Man - Video
Posted in Stem Cells
Comments Off on FameLab Hong Kong 2014 Finalist: "Pluripotency – The power of stem cells" by Lo Lok Man – Video
Immune cells regulate blood stem cells
Posted: February 21, 2014 at 10:49 pm
21.02.2014 - (idw) Universitt Bern
Researchers in Bern have discovered that, during a viral infection, immune cells control the blood stem cells in the bone marrow and therefore also the body's own defences. The findings could allow for new forms of therapy, such as for bone marrow diseases like leukaemia. During a viral infection, the body needs various defence mechanisms amongst other things, a large number of white blood cells (leukocytes) must be produced in the bone marrow within a short period of time. In the bone marrow, stem cells are responsible for this task: the blood stem cells. In addition to white blood cells, blood stem cells also produce red blood cells and platelets.
The blood stem cells are located in specialized niches in the bone marrow and are surrounded by specialized niche cells. During an infection, the blood stem cells must complete two tasks: they must first recognise that more blood cells have to be produced and, secondly, they must recognise what kind of.
Now, for the first time, researchers at the Department of Medical Oncology at the University of Bern and Bern University Hospital headed by Prof. Adrian Ochsenbein have investigated how the blood stem cells in the bone marrow are regulated by the immune system's so-called T killer cells during a viral infection. As this regulation mechanism mediated by the immune system also plays an important role in other diseases such as leukaemia, these findings could lead to novel therapeutic approaches. The study is being published in the peer-reviewed journal Cell Stem Cell today.
T Killer cells trigger defences
This mechanism is important in order to fight pathogens such as viruses or bacteria. However, various forms of the bone marrow disease leukaemia are caused by a malignant transformation of exactly these blood stem cells. This leads to the formation of so-called leukaemia stem cells. In both cases, the mechanisms are similar: the good mechanism regulates healthy blood stem cells during an infection, whilst the bad one leads to the multiplication of leukaemia stem cells. This in turn leads to a progression of the leukaemia.
This similarity has already been investigated in a previous project by the same group of researchers. We hope that this will enable us to better understand and fight infectious diseases as well as bone marrow diseases such as leukaemia, says Carsten Riether from the Department of Clinical Research at the University of Bern and the Department of Medical Oncology at Bern University Hospital and the University of Bern.
Publication details Christian M. Schrch, Carsten Riether, Adrian F. Ochsenbein: Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells, Cell Stem Cell, 20 February 2014, in press. http://dx.doi.org/10.1016/j.stem.2014.01.002 Weitere Informationen:http://www.kommunikation.unibe.ch/content/medien/medienmitteilungen/news/2014/bl...
Read more:
Immune cells regulate blood stem cells
Posted in Stem Cells
Comments Off on Immune cells regulate blood stem cells
Stem Cells from Fat Tissue Show Promise in Reconstructive Surgeries for Face and Skull
Posted: February 21, 2014 at 10:49 pm
Durham, NC (PRWEB) February 21, 2014
A new study released today in STEM CELLS Translational Medicine shows that many patients with defects to the skull, face or jaw bone might benefit from reconstructive surgery combining stem cells taken from adipose (fat) tissue seeded on resorbable scaffolds.
These defects can be due to congenital malformations, such as cleft lip and palate, or to traumatic injuries or surgery to remove a tumor. The use of a patients own bone is still considered the gold standard for reconstructing these defects, but this requires yet another surgery to harvest the bone for the reconstructive procedure. The STEM CELLS Translational Medicine study tracked the case of 13 patients undergoing regenerative medicine procedures.
To our knowledge, this study represents the first GMP-compliant application for autologous adipose-derived stem cells in the treatment of defects at various sites of the cranio-maxillofacial skeleton, said the studys lead investigator, George K. Sndor, M.D., DDS, Ph.D., of the University of Tampere (UT), Tampere, Finland. He and Susanna Miettinen, Ph.D., were lead investigators on the study conducted by scientists and clinicians who, in addition to UT, came from the University of Oulu (Oulu, Finland) and Central Hospital (Jyvskyl, Finland).
Isolated reports of hard tissue (bone) reconstruction in the skull, face or jaw (cranio-maxillofacial skeleton) exist, but multi-patient case series are lacking. This study aimed to review the experience of 13 people with hard tissue defects at four anatomically different sites: the frontal sinus (three cases), cranial bone (five cases), the jaw (three cases) and the nasal septum (two cases).
Stem cells were harvested from adipose tissue in each patients abdomen, treated in the lab and then seeded onto resorbable scaffold materials for implantation back into the patient. The scaffolds were constructed with either bioactive glass or -TCP (a bone graft substitute). In some cases a protein called rhBMP-2, which plays an important role in the development of bone and cartilage, was added, too.
The results were promising. All three of the frontal sinus cases and three of the five cranial defect cases were successfully treated. (The other two cranial cases in which non-rigid resorbable containment meshes were used sustained bone resorption to the point that they required a redo procedure.) One of the two septal perforations failed after a year due to an infection resulting from the patients own actions, but the other healed successfully.
The three patients with reconstructed jaw defects also had good results; in fact, two of them chose to have dental implants placed directly into the stem cell-seeded grafts after healing, allowing these patients to once again enjoy a normal diet.
While the resorption of some of the constructs in the cranial defects was more than expected, Nevertheless, Dr. Sndor said, the majority of these challenging defects 10 of 13 were successfully treated with integration of the stem cell-seeded constructs to the surrounding skeleton at the defect sites. Dr. Miettinen added that the next steps should involve more animal studies and tracking of long-term results in humans.
This case series, involving various sites of defect, illustrates the potential promise of engineering replacement bone in the lab to avoid harvesting bone from the patient, commented Anthony Atala, M.D., editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.
Read more from the original source:
Stem Cells from Fat Tissue Show Promise in Reconstructive Surgeries for Face and Skull
Posted in Stem Cells
Comments Off on Stem Cells from Fat Tissue Show Promise in Reconstructive Surgeries for Face and Skull
From worms to stem cells: Talk gives peek into science of tissue regeneration
Posted: February 21, 2014 at 10:49 pm
There are reports in the news that scientists are attempting to grow human organs in the laboratory, to use 3D printing to replicate tissues, and to tap into the regenerative power of stem cells.
The science behind the headliines will be discussed in Tissue Regeneration, the next offering in the Science in the News series of free public lectures presented by Yale Science Diplomats. The talk will take place at 6:30 p.m. on Tuesday, Feb. 25 in the New Haven Free Public Library, 133 Elm St.
Yale Science Diplomats is a group of graduate students and postdoctoral fellows who are dedicated to making science fun and accessible to people of all ages and backgrounds. In their presentations, the group members (and invited researchers) deconstruct complex scientific topics and explain them in a way that is easy to understand.
In Tissue Regeneration, for instance, participants will learn about planaria, tiny worms that can be cut into hundreds of pieces and still regenerate a whole new worm (some live planaria will be on hand). The presentation will also look at cutting-edge research in regeneration biology and how how scientists are working to translate it from the lab to the clinic.
Yale Science Diplomats aims to provide people with a better understanding of the science underpinning many of the complex issues featured in the news every day; to attract students to STEM fields (science, technology, engineering, and mathematics); and to help policymakers make well-informed decisions on issues related to science. The group members also give presentations at elementary and high school classes in the community and work with teachers to develop hands-on curricula for their classrooms.
The next offerings in the Science in the News series will be: The Origin of Life (March 25), GMOs (April 29), and Quantum Computing (May 27).
For more information, visit the Yale Science Diplomats website.
Continued here:
From worms to stem cells: Talk gives peek into science of tissue regeneration
Posted in Stem Cells
Comments Off on From worms to stem cells: Talk gives peek into science of tissue regeneration
Okyanos Heart Institute CEO Matt Feshbach to Speak on Panel at International Stem Cell Society Global Conference
Posted: February 21, 2014 at 10:45 pm
Freeport, The Bahamas (PRWEB) February 21, 2014
Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, announces CEO Matt Feshbach will present at the STEMSO Conference. He will join a panel to discuss the opportunities available through the new stem cell research and Therapy Act. The conference will be held at the Grand Lucayan Resort in Freeport, Grand Bahamas, February 19-22, 2014. The panel discussion will be Friday, February 21 from 8:45 9:45 a.m.
The conference, titled Bridging the Gap: Research to Point of Care, brings together medical scientists, clinicians, regulatory experts, and investors to discuss progress in the field of research and clinical protocols and the process of taking promising therapies to fight chronic disease to market in a responsible manner.
Friday opening remarks will be delivered by Ian Rolle, President of Grand Bahama Port Authority from 8:30 a.m. to 8:45 a.m. followed by the panel presentation until 9:45 a.m. which, in addition to Rolle will include Feshbach, Mitchell Fuerst, Esq., managing partner, Fuerst, Ittleman, David and Joseph. The panel will be moderated by Arthur K. Parris, Jr. of Parris Whittaker.
"With the passing of the Bahamas Stem Cell Research and Therapy Act, which requires high standards of patient safety and care, we believe the Bahamas is an ideal location to bring internationally-approved, adult stem cell technology to patients with unmet medical needs such as chronic coronary artery disease (CAD), says Feshbach. I am pleased to discuss the opportunities available in the Bahamas with investors, doctors and other stakeholders interested in making the Bahamas a world-class destination for adult stem cell therapy."
The STEMSO 2014 Conference in Freeport, Grand Bahama poses a unique opportunity for medical organizations which focus on adult stem cell-based medical treatments, states Douglas Hammond, president of STEMSO. This conference will provide companies looking to expand their research or clinical practices to offshore locations many good reasons to choose the Bahamas. Those attending will be able to network and view the most advanced research and clinical protocols utilizing autologous and allogeneic stem cells in the world today.
The complete agenda can be found on the organizations website at http://www.stemso.org. Other speakers include stem cell researchers, scientists and practitioners from around the world with leading discoveries in the field, and investors in the healthcare space.
Registration is open for attending and exhibiting on STEMSOs website.
ABOUT OKYANOS HEART INSTITUTE: (Oh key AH nos) Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive procedure, can stimulate the growth of new blood vessels, a process known as angiogenesis. Angiogenesis facilitates blood flow in the heart, which supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos, the Greek god of rivers, symbolizes restoration of blood flow. For more information, go to http://www.okyanos.com/.
NEW MEDIA CONTENT: Okyanos LinkedIn Page: http://www.linkedin.com/company/okyanos-heart-institute Okyanos Facebook Page: https://www.facebook.com/OKYANOS Okyanos Twitter Page: https://twitter.com/#!/OkyanosHeart Okyanos Google+ Page: https://plus.google.com/+Okyanos/posts Okyanos You Tube Physician Channel: http://www.youtube.com/user/okyanosforphysicians
Follow this link:
Okyanos Heart Institute CEO Matt Feshbach to Speak on Panel at International Stem Cell Society Global Conference
Posted in Stem Cell Therapy
Comments Off on Okyanos Heart Institute CEO Matt Feshbach to Speak on Panel at International Stem Cell Society Global Conference
New Stemcell Breakthrough Story on ABC15 – Video
Posted: February 21, 2014 at 5:40 am
New Stemcell Breakthrough Story on ABC15
Watch this story that ran on ABC 15 in Phoenix about how Arizona Pain is treating patients using stem cells. Check out our Stem Cell page: http://arizonapain...
By: Arizona Pain
Originally posted here:
New Stemcell Breakthrough Story on ABC15 - Video
Posted in Stem Cell Videos
Comments Off on New Stemcell Breakthrough Story on ABC15 – Video
$5 billion initiative proposed for stem cell research
Posted: February 21, 2014 at 4:53 am
Supporters of Californias multibillion-dollar stem cell program plan to ask for $5 billion more to bring the fruits of research to patients.
Robert Klein, a leader of the 2004 initiative campaign that established the program, said Thursday hes going to be talking with California voters about the proposal. If the public seems receptive, backers will work to get an initiative on the 2016 ballot to extend funding for the California Institute for Regenerative Medicine
Klein outlined the proposal Thursday at UC San Diego Moores Cancer Center, during a symposium on how to speed research to patient care.
Since cancer cells and stem cells share some underlying characteristics, CIRM has funded research into those similarities, including the work of Moores Cancer Center researchers David Cheresh and Catriona Jamieson.
Klein said supporters, including researchers, patients and patient advocates need to educate the public about the benefits of funding stem cell research, and the results to date. A former chairman of CIRM, Klein is no longer formally affiliated with the agency but continues to support its work.
No stem cell treatments funded by CIRM have been approved, but patients have benefited in other ways. CIRM-funded research into cancer stem cells led to a clinical trial of a drug that caused remission of a bone marrow cancer in Sandra Dillon, a patient of Jamiesons. Moreover, California has vaulted into prominence in regenerative medicine, and the field has also provided a new growth engine for the states large biotech industry.
Though CIRM has been praised for advancing quality research, it has been criticized for being slow to fund commercialization by life science companies.
In addition, CIRM has been criticized for a lack of transparency and conflicts of interest in how it awards grants. The agency revamped its policies last year to forbid members of its governing oversight committee from voting on proposals to fund research at their own institutions.
California voters set aside $3 billion in bond money for CIRM in 2004 under Proposition 71. The money is expected to run out around 2017, so Klein and other supporters have been preparing to go back to the public. The amount paid back will be $6 billion, including interest over the life of the bonds, Klein noted. So the $5 billion for CIRM would require a $10 billion bond measure.
Can it be done again? Klein asked. If we continue to have the extraordinary results the scientists and research institutes are presenting, as well as the biotech sector.
View post:
$5 billion initiative proposed for stem cell research
Posted in Cell Medicine
Comments Off on $5 billion initiative proposed for stem cell research
Stem Cells Being Used To Treat Knee, Joint Pain
Posted: February 20, 2014 at 8:51 pm
CBS Pittsburgh (con't)
Affordable Care Act Updates: CBSPittsburgh.com/ACA
Health News & Information: CBSPittsburgh.com/Health
PITTSBURGH (KDKA) After injuries from gymnastics and dance when she was younger, Linda Morning-Starpoole was having terrible knee pain.
Sitting and standing up and getting up and moving, Linda said.
The news from her orthopedic surgeon was not encouraging.
I was sent off with a prescription, and basically said, take this, and when it gets so bad, well take out your knees. And that was really upsetting to me. It was such an ugly picture that was painted for my future, Linda said.
Traditional treatment might involve steroid injections, physical therapy, and joint replacement.
But Linda wanted an alternative. When she first heard about using stem cell injections, she was very intrigued.
The thought of me healing me with my own self is what sold me on the procedure, Linda said.
Read the original:
Stem Cells Being Used To Treat Knee, Joint Pain
Posted in Stem Cells
Comments Off on Stem Cells Being Used To Treat Knee, Joint Pain
Dr. Max Gomez: Gene Therapy Could Be Lifesaver For Cancer Patients
Posted: February 20, 2014 at 8:48 pm
CBS New York (con't)
Affordable Care Act Updates: CBSNewYork.com/ACA
Health News & Information: CBSNewYork.com/Health
NEW YORK(CBSNewYork) It has been called the cancer breakthrough of the year by a major scientific journal.
Therapy that eradicates cancer using a patients own cells has already saved a number of terminal leukemia patients, CBS 2s Dr. Max Gomez reported.
It has been the Holy Grail of cancer therapy and it harnesses the patients own immune system to attack cancer.
Now, a major new study has shown how to do that when treating leukemia. It involves using gene therapy to convert a patients white blood cells into killers.
Ive had several doctors tell me there is nothing else that can be done, leukemia patient Paolo Cavalli said, It is difficult with a new family to think about those things.
After six years of chemotherapy, stem cell transplants, and multiple relapses Cavalli was out of options for his leukemia.
I dont think I had many days left, he said.
Follow this link:
Dr. Max Gomez: Gene Therapy Could Be Lifesaver For Cancer Patients
Posted in Gene therapy
Comments Off on Dr. Max Gomez: Gene Therapy Could Be Lifesaver For Cancer Patients
Duke Health System CEO appointed to head Institute of Medicine
Posted: February 20, 2014 at 8:46 pm
Duke University Health SystemDr. Victor J. Dzau, the current president and CEO of Duke University Health System
Dr. Victor J. Dzau, the current president and CEO of Duke University Health System and chancellor for health affairs at Duke University, has been appointed to a six-year term as the next president of the Institute of Medicine (IOM), effective July 1, 2014. Dr. Dzau will take over the lead role from Dr. Harvey Fineberg, who served in the position for twelve years.
Dr. Dzau began his career in medicine as a cardiologist, having previously taught at Harvard Medical School and served as chair of the department of medicine. He also worked at Brigham and Womens Hospital as the director of research. His ongoing award-winning research has been key in the development of cardiovascular drugs, as well as techniques to repair tissue damage from heart attacks and heart disease using stem cell therapies.
Dr. Eugene Braunwald, often called the father of modern cardiology and a professor of medicine at Harvard Medical School, has known Dr. Dzau for more than 40 years and worked with him at many different stages of his career at Brigham and Womens Hospital and Partners Healthcare. In an interview Wednesday he called the upcoming IOM president a force of nature.
He is what I would call a talented, quadruple threat. A great physician, inspiring teacher, and a very creative scientist, said Dr. Braunwald, who trained Dzau when he was a resident at Brigham and Womens and continued to work with him on cardiovascular research when Dr. Dzau became chief resident, and then faculty at Harvard Medical School. The quadruple threat is that he also sees the larger picture. Hes interested in areas of medicine that most academic physicians have stayed away from. His work and ideas in global and community-based medicine have left an important heritage at each institution where hes worked.
After nearly a decade at Duke, Dr. Dzaus leadership has been credited with the launch of a number of innovative and global-focused medical institutions, including the Duke-National University of Signapore Graduate Medical School, Duke Global Health Institute, Duke Institute for Health Innovation, Duke Cancer Institute, as well as the Duke Translational Medicine Institute.
Im deeply honored to become the next president of the IOM and recognize the critically important role that the IOM will have in improving the health of the nation at a time of extraordinary evolution in biomedical research and health care delivery, Dzau said in a press release from Duke University Health System. The explosion of new data resources, novel technologies and breathtaking research advances make this the most promising time in history for driving innovations that will improve health care delivery, outcomes and quality.
As the health sciences extension of the National Academy of Sciences, the Institute of Medicine is known for its leadership in advancing health sciences and objective medical research nationally as a nonprofit academic research organization. The outgoing IOM president, Dr. Harvey Fineberg (previously Dean of the Harvard School of Public Health) has lead the nonprofit for twelve years. His focus and research have centered around public health policy and an improvement in informed medical decision making.
This leaves the medical community wondering what Dr. Dzau will bring to the Institute.
As a former chairman of the Association of Academic Health Centers (AAHC), Dr. Dzau advocated for the innovative transition of academic medical and health centers into institutions that can survive the rapid transitions in the health care industry. In a recent article in the New England Journal of Medicine, Dr. Dzau discusses the uncertain future of academic medical centers. He argues that industry pressures and cost restraints from the Affordable Care Act limit the research and education-based missions of teaching hospitals.
Continue reading here:
Duke Health System CEO appointed to head Institute of Medicine
Posted in Cell Medicine
Comments Off on Duke Health System CEO appointed to head Institute of Medicine